JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020 Apr 9, 2020 10:10AM
Ceapro Inc. to Present at Noble Capital Markets’ 16th Annual Investor Conference Feb 10, 2020 08:47AM
Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent Feb 5, 2020 08:05AM
Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent Feb 5, 2020 08:05AM
Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF Jan 31, 2020 09:00AM


Jan 31, 2020 09:00AM Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF
Dec 17, 2019 08:00AM Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids
Nov 13, 2019 09:00AM Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights
Oct 29, 2019 08:05AM Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
Oct 16, 2019 07:00AM Ceapro Begins Trading on the OTCQX Best Market
Oct 16, 2019 07:00AM OTC Markets Group Welcomes Ceapro Inc. to OTCQX